These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 21268919)
1. [Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment]. Sapian-Raczkowska B; Rabczyński M; Adamiec R Pol Merkur Lekarski; 2010 Nov; 29(173):325-7. PubMed ID: 21268919 [TBL] [Abstract][Full Text] [Related]
3. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487 [TBL] [Abstract][Full Text] [Related]
4. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes. Sampson MJ; Braschi S; Willis G; Astley SB Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770 [TBL] [Abstract][Full Text] [Related]
5. Gene delivery of paraoxonase-1 inhibits neointimal hyperplasia after arterial balloon-injury in rabbits fed a high-fat diet. Miyoshi M; Nakano Y; Sakaguchi T; Ogi H; Oda N; Suenari K; Kiyotani K; Ozono R; Oshima T; Yoshida T; Chayama K Hypertens Res; 2007 Jan; 30(1):85-91. PubMed ID: 17460375 [TBL] [Abstract][Full Text] [Related]
6. Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers. Van Himbergen T; Roest M; De Waart F; De Graaf J; Voorbij H; Van Tits L; Stalenhoef A Free Radic Res; 2004 Jun; 38(6):553-60. PubMed ID: 15346646 [TBL] [Abstract][Full Text] [Related]
7. Genetic and environmental determinants of the PON-1 phenotype. Roest M; van Himbergen TM; Barendrecht AB; Peeters PH; van der Schouw YT; Voorbij HA Eur J Clin Invest; 2007 Mar; 37(3):187-96. PubMed ID: 17359486 [TBL] [Abstract][Full Text] [Related]
8. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus. Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429 [TBL] [Abstract][Full Text] [Related]
10. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease. Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538 [TBL] [Abstract][Full Text] [Related]
11. Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein. Lakshmy R; Ahmad D; Abraham RA; Sharma M; Vemparala K; Das S; Reddy KS; Prabhakaran D Indian J Med Res; 2010 Apr; 131():522-9. PubMed ID: 20424303 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Kim YJ; Park H; Lee HY; Ahn YM; Ha EH; Suh SH; Pang MG Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):47-52. PubMed ID: 16949193 [TBL] [Abstract][Full Text] [Related]
14. Association between PON 1 polymorphisms, PON activity and diabetes complications. Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520 [TBL] [Abstract][Full Text] [Related]
15. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae. Soran H; Schofield JD; Liu Y; Durrington PN Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614 [TBL] [Abstract][Full Text] [Related]
16. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641 [TBL] [Abstract][Full Text] [Related]
17. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600 [TBL] [Abstract][Full Text] [Related]
18. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. Ferretti G; Bacchetti T; Busni D; Rabini RA; Curatola G J Clin Endocrinol Metab; 2004 Jun; 89(6):2957-62. PubMed ID: 15181084 [TBL] [Abstract][Full Text] [Related]
19. Paraoxonase-1: Characteristics and Role in Atherosclerosis and Carotid Artery Disease. Lioudaki S; Verikokos C; Kouraklis G; Ioannou C; Chatziioannou E; Perrea D; Klonaris C Curr Vasc Pharmacol; 2019; 17(2):141-146. PubMed ID: 29189170 [TBL] [Abstract][Full Text] [Related]
20. Effect of dietary lipids on paraoxonase-1 activity and gene expression. Ferretti G; Bacchetti T Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]